Semler Scientific, Inc. (SMLR) Dividend History

Semler Scientific, Inc. (SMLR) is a healthcare technology company that develops and provides remote diagnostic testing solutions, primarily for assessing vascular health. Its products are designed to facilitate early detection and management of peripheral arterial disease (PAD) by healthcare providers, enabling more efficient and accessible patient monitoring through its proprietary testing devices and services.

2340-2348 Walsh Avenue, Suite 2344, Santa Clara, CA, 95051
Phone: 408-627-4557
Website: http://www.semlerscientific.com

Dividend History

Semler Scientific, Inc. currently does not pay dividends

Company News

Bragar Eagel & Squire, P.C. Is Investigating EchoStar, Semler, ADTRAN, and Fulgent and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against EchoStar, Semler Scientific, ADTRAN Holdings, and Fulgent Genetics due to alleged violations of federal securities laws and other unlawful business practices.

GlobeNewswire Inc.

Featured Companies: ADTN FLGT SATS
SMLR Investor News: If You Have Suffered Losses in Semler Scientific, Inc. (NASDAQ: SMLR), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Semler Scientific, Inc. (NASDAQ: SMLR) is under investigation by the Rosen Law Firm for potential securities claims due to allegations of issuing materially misleading business information to the investing public.

GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Semler Scientific Inc. - SMLR

Pomerantz LLP is investigating claims on behalf of investors of Semler Scientific Inc. (SMLR) due to the company's disclosure of a risk of a civil false Claims Act lawsuit by the U.S. Department of Justice and unsuccessful settlement discussions.

GlobeNewswire Inc.
Securities Fraud Investigation Into Semler Scientific Inc. (SMLR) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Semler Scientific Inc. (SMLR) is under investigation for potential securities fraud, with the company disclosing a risk of a civil false Claims Act lawsuit from the U.S. Department of Justice. This news led to a 9.4% drop in the company's stock price.

Benzinga
Bitcoin: Time to Buy the Dip?

Bitcoin's weakness is likely to be short-lived due to temporary headwinds like the Mt. Gox supply shock. Stock Strategist Andrew Rocco explains the opportunity.

Zacks Investment Research

Featured Companies: COIN DELL HUT MARA

Dividend data last updated 06/06/2025 23:21:27 UTC